# BPTH (Bio-Path Holdings, Inc.) - SEC EDGAR Financial Statements

> Bio-Path Holdings, Inc. reported $677K in total assets and a net loss of $9.89M through December 31, 2024 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BPTH
- Markdown: https://convexityos.com/fundamentals/BPTH.md
- SEC CIK: 0001133818
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001133818&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2024 | -- | Dec 31, 2024 |
| Operating Income | FY 2024 | -$11.99M | Operating profit |
| Net Income | FY 2024 | -$9.89M | GAAP bottom line |
| Diluted EPS | FY 2024 | -$4.12 | Split-adjusted |
| Free Cash Flow | FY 2024 | -- | Operating CF less CapEx |
| Cash & ST Investments | Mar 31, 2026 | $12K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | $0 | $37K | $13K | $0 |
| Research & Development | $7.29M | $11.61M | $9.16M | $5.91M | $6.58M | $4.58M | $4.60M | $5.48M | $5.47M | $3.02M |
| Total Operating Expenses | $11.99M | $15.84M | $13.90M | $10.44M | $10.91M | $8.69M | $8.59M | $9.00M | $8.49M | $5.49M |
| **Operating Income** | -$11.99M | -$15.84M | -$13.90M | -$10.44M | -$10.91M | -$8.69M | -$8.59M | -$8.97M | -$8.47M | -$5.49M |
| **EBITDA** | -$11.94M | -$15.76M | -$13.81M | -$10.37M | -$10.84M | -$8.56M | -$8.16M | -$8.55M | -$8.27M | -$5.28M |
| Interest Income | $14K | $36K | $33K | $3.0K | $26K | $94K | $7.0K | $9.0K | $12K | $18K |
| Income Before Tax | -$9.89M | -$16.08M | -$13.87M | -$10.44M | -$10.88M | -$8.60M | -$8.58M | -$7.02M | -$6.75M | -$5.47M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$9.89M | -$16.08M | -$13.87M | -$10.44M | -$10.88M | -$8.60M | -$8.58M | -$7.02M | -$6.75M | -$5.47M |
| Basic EPS | -$4.12 | -$33.63 | -$38.12 | -$31.00 | -$56.60 | -$64.80 | -$287.60 | -$6,396.00 | -$292.00 | -$24.00 |
| **Diluted EPS** | -$4.12 | -$33.63 | -$38.12 | -$31.00 | -$56.60 | -$64.80 | -$287.60 | -$6,396.00 | -$292.00 | -$24.00 |
| Basic Shares Outstanding | 2.4M | 478.0K | 364.0K | 336.2K | 192.3K | 132.8K | 29.9K | 1.3K | 23.2K | 224.4K |
| Diluted Shares Outstanding | 2.4M | 478.0K | 364.0K | 336.2K | 192.3K | 132.8K | 29.9K | 1.3K | 23.2K | 224.4K |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $38K | $275K | $4.05M | $1.98M | $1.82M | $1.32M | $1.87M | $2.29M |
| Total Operating Expenses | $297K | $488K | $4.56M | $3.24M | $2.62M | $2.63M | $3.04M | $3.69M |
| **Operating Income** | -$297K | -$488K | -$4.56M | -$3.24M | -$2.62M | -$2.63M | -$3.04M | -$3.69M |
| **EBITDA** | -- | -$479K | -$4.55M | -$3.24M | -$2.61M | -$2.63M | -$3.01M | -$3.67M |
| Interest Income | -- | -- | -- | -- | -- | $4.0K | $6.0K | -- |
| Interest Expense | -- | -- | $35K | $5.0K | -- | -- | -- | -- |
| **Net Income** | -$270K | -$976K | -$4.60M | -$2.85M | -$2.75M | -$2.12M | -$1.87M | -$3.16M |
| Basic EPS | -- | -- | -$0.55 | -$0.40 | -- | -$0.70 | -$1.16 | -$4.88 |
| **Diluted EPS** | -$0.03 | -$0.11 | -$0.55 | -$0.40 | -- | -$0.70 | -$1.16 | -$4.88 |
| Basic Shares Outstanding | -- | -- | 8.3M | 7.1M | -- | 3.0M | 1.6M | 647.0K |
| Diluted Shares Outstanding | 9.3M | 8.5M | 8.3M | 7.1M | -- | 3.0M | 1.6M | 647.0K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.17M | $1.05M | $10.38M | $23.77M | $13.76M | $20.43M | $1.00M | $5.96M | $9.38M | $8.85M |
| **Cash & Short-Term Investments** | $1.17M | $1.05M | $10.38M | $23.77M | $13.76M | $20.43M | $1.00M | $5.96M | $9.38M | $8.85M |
| Other Current Assets | $1.53M | $1.36M | $1.64M | $1.84M | $928K | $788K | $803K | $353K | $902K | $179K |
| **Total Current Assets** | $3.78M | $3.04M | $15.62M | $26.14M | $15.96M | $21.99M | $2.14M | $7.43M | $10.65M | $9.59M |
| Property, Plant & Equipment, Net | $23K | $76K | $158K | $225K | $231K | $303K | $406K | $654K | $614K | $72K |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $0 | $769K | $929K | $1.09M |
| **Total Non-Current Assets** | $107K | $178K | $356K | $428K | $519K | $670K | $406K | $1.42M | $1.54M | $1.16M |
| **Total Assets** | $3.88M | $3.22M | $15.97M | $26.57M | $16.48M | $22.66M | $2.54M | $8.86M | $12.20M | $10.76M |
| Accounts Payable | $1.27M | $457K | $667K | $106K | $100K | $486K | $587K | $52K | $69K | $54K |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $0 | $12K | $0 |
| **Total Current Liabilities** | $3.29M | $1.91M | $1.68M | $958K | $1.17M | $1.24M | $1.33M | $791K | $1.05M | $937K |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $434K | $873K | $113K | $153K | $236K | $330K | $0 | $0 | $2.91M | $0 |
| **Total Liabilities** | $3.73M | $2.78M | $1.80M | $1.11M | $1.41M | $1.57M | $1.33M | $791K | $3.96M | $937K |
| **Total Debt (incl. Leases)** | $83K | $113K | $221K | $235K | $330K | $415K | -- | -- | -- | $0 |
| Common Stock | $6.0K | $1.0K | $1.0K | $7.0K | $5.0K | $4.0K | $1.0K | $1.0K | $10K | $90K |
| Retained Earnings | -$117.5M | -$107.6M | -$91.53M | -$77.66M | -$67.22M | -$56.34M | -$47.74M | -$39.16M | -$32.13M | -$25.38M |
| **Total Stockholders' Equity** | $154K | $441K | $14.17M | $25.46M | $15.07M | $21.09M | $1.22M | $8.07M | $8.24M | $9.82M |
| Total Equity | $154K | $441K | $14.17M | $25.46M | $15.07M | $21.09M | $1.22M | $8.07M | $8.24M | $9.82M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $12K | -- | $0 | $0 | $100K | $1.17M | $600K | $4.01M |
| **Cash & Short-Term Investments** | $12K | -- | $0 | $0 | $100K | $1.17M | $600K | $4.01M |
| Other Current Assets | $191K | $193K | $189K | $206K | $1.52M | $1.53M | $1.81M | $739K |
| **Total Current Assets** | $677K | $667K | $663K | $680K | $2.12M | $3.78M | $2.90M | $5.02M |
| Property, Plant & Equipment, Net | -- | -- | -- | $9.0K | $21K | $23K | $42K | $48K |
| **Total Non-Current Assets** | $0 | $11K | $27K | $66K | $75K | $107K | $66K | $99K |
| **Total Assets** | $677K | $678K | $690K | $746K | $2.19M | $3.88M | $2.96M | $5.12M |
| Accounts Payable | $5.16M | $4.91M | $4.90M | $3.48M | $2.44M | $1.27M | $1.04M | $766K |
| **Total Current Liabilities** | $9.15M | $8.88M | $8.68M | $7.86M | $4.74M | $3.29M | $3.38M | $3.01M |
| **Total Non-Current Liabilities** | $12K | $14K | $11K | $40K | $40K | $434K | $302K | $817K |
| **Total Liabilities** | $9.16M | $8.90M | $8.69M | $7.90M | $4.78M | $3.73M | $3.68M | $3.83M |
| **Total Debt (incl. Leases)** | -- | $11K | $27K | $57K | $54K | $83K | $26K | $55K |
| Common Stock | $10K | $9.0K | $9.0K | $8.0K | $8.0K | $6.0K | $4.0K | $2.0K |
| Retained Earnings | -$126.4M | -$126.2M | -$125.9M | -$125.0M | -$120.4M | -$117.5M | -$114.7M | -$112.6M |
| **Total Stockholders' Equity** | -$8.49M | -$8.22M | -$8.00M | -$7.16M | -$2.59M | $154K | -$712K | $1.29M |
| Total Equity | -$8.49M | -$8.22M | -$8.00M | -$7.16M | -$2.59M | $154K | -$712K | $1.29M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$9.89M | -$16.08M | -$13.87M | -$10.44M | -$10.88M | -$8.60M | -$8.58M | -$7.02M | -$6.75M | -$5.47M |
| Depreciation & Amortization | $53K | $82K | $88K | $76K | $72K | $134K | $426K | $411K | $204K | $202K |
| Stock-Based Compensation | $566K | $734K | $851K | $821K | $577K | $684K | $554K | $793K | $784K | $369K |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$405K |
| **Operating Cash Flow** | -$10.57M | -$11.54M | -$15.10M | -$9.92M | -$10.96M | -$8.36M | -$6.12M | -$7.96M | -$8.15M | -$5.00M |
| Capital Expenditure | -- | -- | -$21K | -$70K | -- | $0 | -$17K | -$538K | -$338K | $0 |
| **Free Cash Flow** | -- | -- | -$15.12M | -$9.99M | -- | -$8.36M | -$6.14M | -$8.49M | -$8.49M | -$5.00M |
| **Investing Cash Flow** | -- | -- | -$21K | -$70K | -- | $0 | -$17K | -$538K | -$338K | $0 |
| Common Stock Issued | $10.70M | $1.68M | $1.73M | $15.85M | $4.29M | $26.70M | $1.18M | $3.57M | $9.01M | $0 |
| **Financing Cash Flow** | $10.70M | $2.20M | $1.73M | $20.01M | $4.29M | $27.78M | $1.18M | $5.08M | $9.01M | $0 |
| **Net Change in Cash** | $121K | -$9.33M | -$13.39M | $10.02M | -$6.67M | $19.42M | -$4.96M | -- | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$270K | -$976K | -$4.60M | -$2.85M | -$2.75M | -$2.12M | -$5.03M | -$3.16M |
| Depreciation & Amortization | -- | $9.0K | $12K | $2.0K | $19K | $6.0K | $28K | $22K |
| Stock-Based Compensation | $5.0K | $27K | $28K | $108K | $127K | $128K | $311K | $170K |
| **Operating Cash Flow** | -$38K | $0 | -$283K | -$1.31M | -$2.88M | -$3.43M | -$4.27M | -$1.04M |
| Common Stock Issued | -- | -- | -- | -- | $3.49M | -$16K | $7.22M | $174K |
| **Financing Cash Flow** | $50K | $0 | $161K | $262K | $3.49M | -$16K | $7.22M | $174K |
| **Net Change in Cash** | $12K | $0 | -$122K | -$1.05M | $611K | -$3.44M | $2.95M | -$864K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -24232.4% | -65192.3% | -- |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -18981.1% | -51923.1% | -- |
| Return on Equity (ROE) | -6424.7% | -3645.8% | -97.8% | -41.0% | -72.2% | -40.8% | -704.7% | -87.1% | -81.9% | -55.7% |
| Return on Assets (ROA) | -254.8% | -499.3% | -86.8% | -39.3% | -66.1% | -37.9% | -337.2% | -79.3% | -55.3% | -50.8% |
| Current Ratio | 1.15x | 1.60x | 9.27x | 27.29x | 13.65x | 17.68x | 1.61x | 9.40x | 10.15x | 10.24x |
| Quick Ratio | 0.36x | 0.55x | 6.17x | 24.82x | 11.77x | 16.42x | 0.76x | 7.54x | 8.93x | 9.45x |
| Debt to Equity | 0.54x | 0.26x | 0.02x | 0.01x | 0.02x | 0.02x | -- | -- | -- | 0.00x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -100.0% | +184.6% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -- | -6424.7% | -- | -898.3% | -- |
| Return on Assets (ROA) | -- | -1620.0% | -1651.1% | -436.9% | -254.8% | -354.6% | -226.6% | -789.7% |
| Current Ratio | 0.07x | 0.08x | 0.09x | 0.45x | 1.15x | 0.86x | 1.67x | 0.43x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.02x | 0.36x | 0.18x | 1.33x | 0.05x |
| Debt to Equity | -- | -- | -- | -- | 0.54x | -- | 0.04x | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
